Overview

Effectiveness of Selegiline in Treating Marijuana Dependent Individuals - 1

Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
During the past 15 years, the demand for treatment for marijuana-related problems in the United States has increased nearly twofold. Selegiline is a medication currently used to treat nicotine dependence. The purpose of this study is to evaluate whether selegiline may be useful in treating individuals with marijuana dependence.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Treatments:
Selegiline